Angle Share Discussion Threads

[adw198] 21/6/2024 10:58

Yes it would be great if / when things move to the next stage. But we’re investors and given we don’t know when that might be, for how much money and at what costs, it becomes a blind gamble.

Same with product sales. £1-1.3m for half year - how much was product sales and what’s the trajectory of them. Absent of those facts it’s another blind gamble.

[jelenko] 21/6/2024 10:45

Don't ignore product sales in all this.

[htrocka2] 21/6/2024 10:28

The financial targets, although important, are not the 'be-all' and 'end-all'.The most important milestone now is....should 'Eisai Inc' be satisfied with the current study then the project gets moved onto Phase III.



CONTRACT ANNOUNCEMENT WITH LARGE PHARMA COMPANY, EISAI INC.

Pilot study for ANGLE's Portrait HER2 assay in Phase II study of HER2 targeting antibody-drug conjugate, BB-1701

[adw198] 21/6/2024 09:53

If they could have raised £10m they would have done - let’s not kid ourselves this was a reward to shareholders. If you really think the II’s wanted another £2m more at 15p then why haven’t they taken it up now?

Ohwhatfun is so right about the frankly ridiculous revenue target. Had they said something about repeat contracts being close then it might have been credible but they instead pointed to being discussions with large pharma as reasons for their confidence. These deals don’t pay so quickly so there’s no chance imo.
I think it’s largely been missed but the annual report mentioned the bio view work isn’t completing until 2025 now either.

This is going to get really messy because at some point they’ll have to tell the market they’re miles off the revenue, which shortens the runway and makes another raise inevitable, but probably at much much lower prices because when you strip it back you’ve got revenue lagging massively behind income and the gap is barely closing.

It’s a shame but there’s no getting away from the figures.

[ohwhatfun] 21/6/2024 09:17

Mia

You can’t know something big is down the line, until it’s signed it has a zero value

Aim companies insist on a regular basis that huge things are pending, yet 99% of the time nothing materialises.

That’s the rose-tinted sales pitch, all part of the training. Anyone in sales knows that.

There is always a plethora of excuses available for failing to meet targets.

I don’t wish a bad outcome on AGL, it’s just this raise is not enough without hitting all targets, and claims appear to be fiction.


Break even end of 2025!!!

What, £30-£40m of sales next year!!!!

Increased sales mean increased costs.

Cloud cuckoo land.

[ohwhatfun] 21/6/2024 09:08

Bones

I too think the revenue forecast is highly optimistic (understatement) regardless of potential news pending, as even with news it has to fall within the next 6 months in the bank.

To strike deals now for a supply of services/goods would be tight on payments being made in this financial year.

So just a month or 2 really to book the millions in now via contracts, with the supply starting immediately.

A tall order I suspect, I’m expecting the forecast to be missed by some way, with the interims being a point where they will have to admit it, if not earlier.

Then it’s back to the market, begging bowl out to backers they probably shunned at sub 15p.


The cash burn is there for all to see.

End of 2023 £16.2m so just a few months of cash left at the time of the raise, which we warned about, hence the raise coming comments.

Liberal use of the accounting pen to justify a going concern, it must assume substantial savings and all revenue in the bank.🐖✈;️

To back and bet on that is a pure against the odds gamble.

Good luck to all private investors.

[miavoce] 21/6/2024 09:04

Not a disaster at all bones. If the £2m mattered to the company they would have raised the placing to £10m. The OO was tacked onto the fundraise as a sop to existing investors to give the opportunity to buy at the same price as the placing, but as it happened existing investors could get a better price in the market. It would have been nice to get the full £2m but it really wasn't important IMO (and on the plus side the failure to raise £2m limits the dilution).

With regard to the £6m forecast, I agree that this looks challenging given the H1 revenue. However the fact that the directors have expressed confidence that they will meet the £6m forecast indicates to me that they know something big is coming down the line. We shall see.

[kryptonsnake] 21/6/2024 08:36

Only 25% of the open offer was taken up

It was good of those people to put money in at 15p when they could have bought lower

At least we will have 11 million less shares to issue




sent from my iPhone

[muffster] 21/6/2024 08:26

See bone idle is back.What's the point of you keep coming on here with negativity.Great sentiment Spa, I agree.

[spa362] 21/6/2024 08:19

I think we should start moving upwards on the share price over the next little while. It's been a good few weeks and the company is now sufficiently funded to have the headspace it needs to in this active phase of commercialisation. It's had a great start to the year and we can now look forward to more good news.

[bones699] 21/6/2024 07:53

What an utter diaster!

Only 25% of the £2m Open Offer taken up by retail!

Monthly cash burn rate still ridicously high at £2m cash remaining I guess no more than 6 months and expect another placing by September.

"The Open Offer raised gross proceeds of £0.5m at the Issue Price, which will be used to strengthen the Company's balance sheet. In aggregate, £9.3m of gross proceeds have been raised" pursuant to the Placing, Subscription and Open Offer.

[ste2000] 21/6/2024 07:22

Hands up here if you took shares in the placing to help the company despite them being 6 percent cheaper on the open market.

What a set of mugs you boys are

[htrocka2] 20/6/2024 09:57

I agree that the deal with a Pharma such as Eisai is only a pittance...However, they've made it to Phase 11...that's encouraging.

[yasx] 20/6/2024 09:35

The open offer results will be announced tomorrow - one can safely say that there will be very limited take up given the shares have been readily available below that level.

Now it is time to simply sit back and wait for the next significant announcement regarding progress on various fronts.

Until then, the rest is just noise that has been sufficiently discussed on here.

[bones699] 20/6/2024 08:42

"limited risk"

"solid progress being made by the company."

How do you reach that conclusion money raised only lasts 6 months at best and there are no commercial contracts apart fron a couple of puny pilot trials.!

Meanwhile Newlands £6.6m fantasy revenue forecast for this year looks fanciful at best!

👌...#f@@kingdeludedseekhelpfast!

[spa362] 19/6/2024 20:23

Share price now nicely underpinned at around 14-15p ready for next phase of commercialistion. Good level to buy in at with limited risk in my opinion. Feels like this will move into a new upwards range before long based on solid progress being made by the company. Make your own minds up of course as solely my opinion. Am a holder at under 14p

[kryptonsnake] 19/6/2024 09:39

Buyers returning here

Loading up below 15p makes perfect sense

Selling in the 13's doesn't



sent from my iPhone

[spa362] 18/6/2024 20:50

Agree - news upcoming

[gooosed] 18/6/2024 20:38

A significant wait for the next event attended by Angle :



A number of anticipated milestones before that. Now that the AGM date has been confirmed (Thursday 11th July) I suspect that the BoD will want to have something else tangible to smile about as they are "looking forward to welcoming shareholders in person".

As mentioned previously there are updates on Ovarian & Prostate, Solaris Healthcare collaboration, Lab accreditation, 6 of 11 pharma discussions etc. . .

[united snakes of advfn] 18/6/2024 16:52

Poor YasX gets all his information watching the box, Sunak, Callmedave, Bozo and Bliar.


One of the rampers posts, they all come out after each other; I wonder if they are a team.

YasX is making it seem as if the people who bought the placement are still holding. The majority dumped at 22p. when the placement was being arranged at 15p

Ask Timbo; he was offered placing shares at 15p, 10 days before placing at 22p something, and he remains nonchalant about this.

Forward selling means no one holding this dead duck at 15p.

Poor YasX does not have an advisory broker, so he takes chances


Regards,
US of A

[adw198] 18/6/2024 16:50

Presumably the IIs who were keen to have an extra £2m at 15p have been filling their boots at 14p. Doesn’t look that way though!

[yasx] 18/6/2024 16:38

Super,

Correct.

[adw198] 18/6/2024 15:52

@yasx

If they don’t raise the additional £2m then it’s fair to say they weren’t able to raise the money. They’d have taken the lot from II’s if they could, in my opinion.

If there’s anything specific you think is misleading in my posts please be precise. You’ve asserted they
“Could quite easily have raised a further 2 million from investors at 15p had it elected to do so” but what is this based upon?

[supernumerary] 18/6/2024 15:51

yasX - I imagine the open offer was less to do with the board's kindness to small investors than to the provisions regarding disapplication of pre-emption rights in the Companies Act.